Literature DB >> 8031230

Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

S T Higgins1, A J Budney, W K Bickel, F E Foerg, R Donham, G J Badger.   

Abstract

OBJECTIVE: To assess whether incentives improved treatment outcome in ambulatory cocaine-dependent patients.
METHOD: Forty cocaine-dependent adults were randomly assigned to behavioral treatment with or without an added incentive program. The behavioral treatment was based on the Community Reinforcement Approach and was provided to both groups. Subjects in the group with incentives received vouchers exchangeable for retail items contingent on submitting cocaine-free urine specimens during weeks 1 through 12 of treatment, while the group without incentives received no vouchers during that period. The two groups were treated the same during weeks 13 through 24.
RESULTS: Seventy-five percent of patients in the group with vouchers completed 24 weeks of treatment vs 40% in the group without vouchers (P = .03). Average durations of continuous cocaine abstinence documented via urinalysis during weeks 1 through 24 of treatment were 11.7 +/- 2.0 weeks in the group with vouchers vs 6.0 +/- 1.5 weeks in the group without vouchers (P = .03). At 24 weeks after treatment entry, the voucher group evidenced significantly greater improvement than the no-voucher group on the Drug scale of the Addiction Severity Index (ASI), and only the voucher group showed significant improvement on the ASI Psychiatric scale.
CONCLUSIONS: Incentives delivered contingent on submitting cocaine-free urine specimens significantly improve treatment outcome in ambulatory cocaine-dependent patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031230     DOI: 10.1001/archpsyc.1994.03950070060011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  186 in total

1.  Weekly patterns of drug treatment attendance.

Authors:  D S Svikis; R W Pickens; W Schweitzer; E Johnson; N Haug
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

Review 2.  Monetary-based consequences for drug abstinence: methods of implementation and some considerations about the allocation of finances in substance abusers.

Authors:  Jesse Dallery; Bethany Raiff
Journal:  Am J Drug Alcohol Abuse       Date:  2011-12-13       Impact factor: 3.829

3.  A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period.

Authors:  Adam Bisaga; Efrat Aharonovich; Wendy Y Cheng; Frances R Levin; John J Mariani; Wilfrid N Raby; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

4.  Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker.

Authors:  Michael G McDonell; Donelle N Howell; Sterling McPherson; Jennifer M Cameron; Debra Srebnik; John M Roll; Richard K Ries
Journal:  J Appl Behav Anal       Date:  2012

Review 5.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

6.  How to design an effective treatment outcome study.

Authors:  Lisa M Najavits
Journal:  J Gambl Stud       Date:  2003

7.  A tale of two cities: financing two voucher programs for substance abusers through community donations.

Authors:  Leslie Amass; Jonathan Kamien
Journal:  Exp Clin Psychopharmacol       Date:  2004-05       Impact factor: 3.157

Review 8.  Choosing a behavioral therapy platform for pharmacotherapy of substance users.

Authors:  Kathleen M Carroll; Thomas R Kosten; Bruce J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

9.  Exploring the limits and utility of operant conditioning in the treatment of drug addiction.

Authors:  Kenneth Silverman
Journal:  Behav Anal       Date:  2004

10.  A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.

Authors:  Michelle L Miller; Amira Y Moreno; Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Brittani D Vaillancourt; M Jerry Wright; Kim D Janda; Michael A Taffe
Journal:  Biol Psychiatry       Date:  2012-10-23       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.